Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AYTU BioPharma Inc | AYTU | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.80 | 07:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.80 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.38 - 3.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 2.80 | USD |
AYTU BioPharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 15.59M | 5.57M | - | 107.4M | -17.05M | -3.06 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AYTU BioPharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AYTU Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.89 | 2.932 | 2.63 | 2.78 | 7,978 | -0.09 | -3.11% |
| 1 Month | 3.10 | 3.38 | 2.63 | 3.01 | 16,728 | -0.30 | -9.68% |
| 3 Months | 2.66 | 3.45 | 2.48 | 3.01 | 21,846 | 0.14 | 5.26% |
| 6 Months | 2.62 | 3.45 | 2.20 | 2.79 | 28,266 | 0.18 | 6.87% |
| 1 Year | 2.69 | 3.50 | 1.38 | 2.45 | 73,977 | 0.11 | 4.09% |
| 3 Years | 136.20 | 144.00 | 1.38 | 30.26 | 489,497 | -133.40 | -97.94% |
| 5 Years | 40.00 | 235.286 | 1.38 | 34.79 | 2,191,517 | -37.20 | -93.00% |
AYTU BioPharma Description
| Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. |
